How can behavioral science and implementation science help cancer health systems to regain lost ground post-pandemic and strengthen provision to address cancer burden in the future? Insights from research and innovation in the Global South, EU, UK, and US

How can behavioral science and implementation science help cancer health systems to regain lost ground post-pandemic and strengthen provision to address cancer burden in the future? Insights from research and innovation in the Global South, EU, UK, and US

Plenary C (level 0)
Regular session

Information

Session organised by Cancer Research UK

Chaired by Kate Hamilton-West, Cancer Research UK Head Office (United Kingdom)

Presentations:

1. Using Behavioral Science to understand barriers and enablers of HPV vaccination uptake in the Global South and inform the design, evaluation and scale-up of behavior change interventions. - Kriti Chouhan, Busara (India)

2. Applying behavioural science to understand perceptions and adoption of cancer prevention recommendations amongst European Union citizens. - Ariadna Feliu Josa, International Agency for Research on Cancer (IARC/WHO) (France)

3. Designing and delivering a “Test Evidence Transition” Program to address the ‘implementation gap’ in cancer care and enable the effective and equitable transition of evidence-based innovation into mainstream practice across health systems. - Kate Hamilton-West, Cancer Research UK Head Office (United Kingdom)

4. Advancing the integration of behavioral research in cancer prevention and control: progress, opportunities, and strategies to address implications of the COVID-19 pandemic. - William Klein, National Cancer Institute (United States)

Theme
2. Cancer research and progress
Objectives
We aim to illustrate the role of behavioral and implementation science in addressing challenges facing health systems around the globe, including tackling cancer risk factors, reducing reliance on misinformation, increasing public participation in cancer screening and HPV vaccination programs, empowering people to seek help earlier, enabling clinicians to adopt best practice, and advancing evidence-based innovations to scale. The need for this work is discussed in relation to the coronavirus (COVID-19) pandemic, which undermined many cancer-relevant behaviors and starkly highlighted the effects of economic and health inequities present in access to healthcare and cancer treatment (Klein et al. 2022). This session is relevant to a wide range of audiences, including students, academics, clinicians, health systems leaders, policy makers, government and non-government organisations, advocacy organisations, charities, and non-profit organisations. We will provide examples of relevant tools and datasets for public use such as Cancer Research UK’s Cancer Awareness Measure, the National Cancer Institute’s Health Information National Trends Survey (HINTS), Busara’s 'Little Book of Jabs’ and NCI’s searchable database of Evidence Based Cancer Control Programs (EBCCP) where researchers and interventionists can read about and download evidence-based intervention materials.

Log in